Epetraborole

DB11744InvestigationalSmall molecule

Epetraborole has been used in trials studying the treatment of Infections, Bacterial, Infections, Intestinal, Infections, Urinary Tract, and Community-acquired Infection.

Chemical structure of Epetraborole
Formula / weight
C11H16BNO4 · 237.06 g/mol (avg)
Code names
AN-3365 · GSK-2251052

Resolves to

Compound
UNII6MC93Z2DF9CAS1093643-37-8ChEMBLCHEMBL3549142PubChem46836890
Structure
InChIKeyFXQIIDINBDJDKL-SNVBAGLBSA-NSMILESNC[C@H]1OB(O)C2=C1C=CC=C2OCCCO

What you can answer from here — as of August 30, 2026

56Drug interactionsStructured to mechanism, not free text
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Epetraborole, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In